Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

Bo Zhang(Gansu Agricultural University), Wenying Yang(China-Japan Friendship Hospital), Linong Ji(Peking University), Hongwei� Jiang(First Affiliated Hospital of Henan University of Science and Technology), Shenglian Gan(The First People's Hospital of Changde), Ting Yu, Huan Deng(Nanfang Hospital), Jianhua Ma(Sun Yat-sen University), Lei Qian, Jianjun Yi, Guixia Wang(Jilin University), Li Li, Xin Zhang(Sichuan Cancer Hospital), Haoyu Li(Qingdao University), Zhifeng Cheng(Harbin Medical University), Xiaoyun Wang, Pei An(Peking University), Ji Chen, Ping Jin(Second Affiliated Hospital of Xi'an Jiaotong University), Guoqing Ma(First Affiliated Hospital of Heilongjiang University of Chinese Medicine), Shandong Ye(Anhui Provincial Hospital), Bimin Shi(Soochow University), Juan Sun(Xuzhou Medical College), Qingyang Ma, Dexue Liu(Nanyang Medical College), Xuejiang Gu(Shanghai Jiao Tong University)
Diabetes Care
November 9, 2023
10.2337/dc23-1287
Cited by 80

Related Papers

Prevalence of Diabetes among Men and Women in China
|New England Journal of Medicine|2010|3.1k
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china
|Annals of Neurology|2011|507
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial
|BMJ|2022|494
Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study
|Diabetologia|2010|253
Impact of Waist Circumference and Body Mass Index on Risk of Cardiometabolic Disorder and Cardiovascular Disease in Chinese Adults: A National Diabetes and Metabolic Disorders Survey
|PLoS ONE|2013|179